Singapore: in-vitro diagnostics revenue 2029

The revenue in the 'In Vitro Diagnostics' segment of the medical technology market in Singapore was forecast to continuously increase between 2024 and 2029 by in total 49.9 million U.S. dollars (+28.91 percent). After the sixth consecutive increasing year, the revenue is estimated to reach 222.49 million U.S. dollars and therefore a new peak in 2029.

Find further information concerning the revenue in the 'Diagnostic Imaging Devices' segment of the medical technology market in Indonesia and the revenue in the 'Medical Devices' segment of the medical technology market in Indonesia.

The Statista Market Insights cover a broad range of additional markets.

Revenue of the in-vitro diagnostics segment of the medical technology market in Singapore from 2016 to 2029 (in million U.S. dollars)

Characteristic	In million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

Definition:
The market In Vitro Diagnostics (IVD) consists of medical instruments and accessories used to perform tests with the help of biological samples. In Vitro Diagnostics provide valuable information used for detection, prognosis, prevention, and therapeutic monitoring of diseases.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Roche Diagnostics, Abbott Laboratories, Danaher, Siemens Healthineers.
Further information on the key players can be found in the Market Shares boxes.

Citation formats